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1. Introduction
  Parkinson’s disease (PD) is a common central nervous 
system degenerative disease characterized symptoms such 
as resting tremor, hypermyotonia and bradykinesia. The 
pathological basis of PD is the degeneration of substantia 
nigra of midbrain dopaminergic neurons and the formation 
of Lewy’s body. The main lesions are confined in the 
dopaminergic cell aggregation area such as substantia 
nigra of midbrain, dorsal nucleus of vagus nerve and so 
on, resulting in deformation and necrosis of dopaminergic 
cells, reduced production of dopamine and imbalance of 
dopaminergic system and acetyl cholinergic system, thus 
causing a series of clinical symptoms.  
  Numerous animal experiments have shown that neural 
stem cells (NSCs) transplantation is an effective therapeutic 
method for PD[1-4]. However, the results of clinical trials are 
still not satisfactory[5-7]. It has been indicated that Schwann 
cells (SCs) could promote the proliferation of embryonic 
stem cells and differentiation to dopamine neurons in 
vitro[8]. The purpose of our experiment was to observe 
whether macaque autologous SCs and human embryonic 
NSCs co-transplantation could enhance the therapeutic 
effects of cell transplantation on PD, thus providing a basis 
for pre-clinical experiments.
2. Materials and methods 
2.1. Animals and groups
  Three healthy adult macaques including two males and 
one female, aged 5-10 years old, weighing 8-12 kg, were 
purchased from the Animal Center, Chinese Academy of 
Science. Macaques were fed in cage separately with food 
and fruit. Three different transplants were adopted in three 
macaques, including PBS control group, NSCs group and SCs 
plus NSCs group. 
Objective: To investigate the therapeutic effects of co-transplantation with Schwann cells (SCs) 
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Ying Xia et al./Asian Pacific Journal of Tropical Medicine (2012)7-148
2.2. PD modeling 
  Stereotactic surgery was performed with NARISHIGE SN-2 
stereotaxic apparatus in a clean air-conditioned laboratory. 
2 mg/mL 6-hydroxy dopasolution (Sigma) was prepared. 
Basic anesthesia was carried out by intramuscular injection 
of 8 mg/kg ketamine, followed by intraperitoneal injection of 
25 mg/kg pentobarbital, intramuscular injection of 0.1-0.15 mL
of 0.5 mg/mL atropine and 0.2 mL of muscle relaxants 
(Bayer Corporation, used for cats and dogs). The ear bars 
were accurately inserted into external auditory canals. 
The readings of two ears bars were kept equal. About 2 cm 
sagittal incision was made 5 mm from the median sagittal 
line, with the site 7 mm from the biauricular line as the 
center. The scalp and periosteum were pulled out, and an
8 mm diameter cranial window was opened with a drill.  
  After zero calibration of the stereotaxic apparatus, 10毺L
solution (containing 20 毺g 6-OH dopa ) was extracted 
with a Hamilton microsyringe and injected in the following 
standard targets in order (Table 1). The injection time was
5 min, and the needle was kept for 8 min. 20 sec interval was 
kept after each 1 mm withdrawing needle within the former 
10 mm, and the withdrawing needle was faster slightly 
within the later 10 mm. After injection, the head wound 
was washed with 3% hydrogen peroxide and Gentamicin 
sodium chloride. The continuous suture was carried out for 
periosteum, and interrupted suture was carried out for scalp. 
2.3. Culture, purification and identification of macaque SCs 
  Autogeneic SCs culture and identification were performed 
in the co-transplanted macaque 4 months after successful 
modeling. 
2.3.1.Nerve ligation
  Ectogluteus injection anesthesia was performed with 
8 mg/kg ketamine. After routine disinfection, 2 cm skin 
incision was made behind the leg 3-5 cm above the 
external malleolus. The sural nerve was separated by blunt 
dissection. The nerve was ligated with sutural line near the 
superior extremity of the incision. The skin was sutured and 
sterilized.
2.3.2. Culture of SCs  
  7 days after nerve ligation, 1 cm nerve segment was 
obtained under the ligation site under sterile conditions. The 
nerve segment was placed into 4 ℃ of D-Hank buffer, and 
the skin was sutured. The adhesive tissue around the nerve 
was removed under an operation microscope. The nerve tract 
was pulled out from the epineurium, and the perineurium 
was removed. The nerve was cut into 1 mm segments, with 
50 explants in each segment. The nerve segments were 
implanted into rat tail collagen pre-coated 35 mm diameter 
plate. The culture medium contained 20% calf serum and 
80% DMEM (Gibco Company). The plate was placed in 37 ℃ 
incubator (Heraeus) with 5% carbon dioxide. Medium was 
replaced every other day.
2.3.3. Passage and purification of SCs 
  Fibroblasts were removed with repeated “explant method”. 
When SCs covered 100% of the plate, the explants were 
transplanted into a new plate. The explant-removed SCs 
were digested for passage with 0.25% trypsin plus 0.01% 
EDTA (1:1). Immunocytochemical staining for S-100 protein 
was performed with PAP method. The percentage of S-100 
positive cells to total cells was the purity of SCs. 
2.4. Harvest, culture and identification of NSCs in human 
embryonic mesencephal tissue
  Stem cells were obtained from two 8-10 weeks aborted 
embryonic mesencephal tissues, which were approved by 
hospital ethics committee and the pregnant women. 
2.4.1. Sampling
  Mesencephalon of fetus was obtained and placed into 
D-Hank solution. After cleaning, the tissue was cut into 
pieces and put into 1.5 mL centrifuge tube. Tissue was 
digested for 20 min with 1 mL 0.125% trypsin at 37 ℃, and 
digestion was stopped with 50 毺L of 1% trypsin inhibitor. 
Then the digestion product was centrifuged at 1 000/min 
for 10 min, and the supernatant was removed. The pipette 
was placed into appropriate amount of cold D-Hank 
solution in a new 10 mL centrifuge tube, and mixed gently 
with capillary until the suspension became white. The 
suspension was filtered with 200 meshes stainless steel 
filter, and the supernatant was removed. DMEM/F12 culture 
medium (containing 1% N2, 2% B27 and 20 ng/mL BFGF) 
was added into tube. The proportion of the dead cells to the 
active cells was detected with trypan blue staining. Cells 
were seeded into 25 mL culture flask as 5×106/mL density, 
and incubated at 37 ℃ with 5% CO2 as suspension culture. 
According to cell growth rate and the pH value, half of the 
medium was changed per 2 to days. After that, cells were 
passaged once by mechanical digestion per 5-7 d, and the 
method was same with the previous method. The 1:2 passage 
method was used in our study. The original generation nerve 
spheres were made into single cell suspension, and then 
cultured. 
2.4.2. Identification of NSCs
  Suspension cultured nerve spheres were planted into 
polylysine (50 毺g/mL) pro-coated 24-well plate. Cells 
were fixed with 4% paraformaldehyde for 30 min, and then 
indirect cell immunofluorescence was performed. The steps 
were shown as follows: Cells were washed with 0.01 M PBS 
for three times, and then cell membrane was perforated with 
0.1% Triton. Cells were blocked with normal goat serum, 
and then incubated with the primary antibody against nestin 
(1:5 000) in the humid box at 4 ℃ overnight. Cells were 
washed with 0.01M PBS for three times, and then incubated 
with IgG-CY3 flourescence second antibody (1:5 000) at room 
temperature for 1 h, and then cells were observed under 
fluorescence microscope and photos were obtained. 
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2.5. Preparation of transplant cell suspension before 
transplantation
2.5.1. Preparation of SCs suspension
  SCs were washed with 10% FCS+90% DMEM for three times 
and with D-Hank twice 2 h before transplant operation. 
Then cells were digested with 0.25% trypsin, and then 
centrifuged. 1伊107/mL cell suspension was prepared with 
PBS, and then placed into a 4 ℃ refrigerator. 
 2.5.2. Preparation of human embryonic NSCs suspension
  Nerve stem cell suspension was prepared 2 h before 
transplantation. All mesencephal nerve stem cell spheres 
in the 6th passage were collected. After centrifugation, cells 
were digested with 0.25% trypsin-EDTA at 37 ℃ for 15-
20 min. Digestion was stopped with 10% fetal calf serum. 
Cell suspension was mixed gently, and cell density was 
adjusted with PBS to 1伊108/mL, and rapidly stored in a 4 ℃ 
refrigerator.
2.6. Cell transplantation   
  Transplantation was carried out 6 months after 6-OHDA 
unilateral PD modeling. Three grafts were adopted for 
three macaques. PBS was injected in the right striatum of 
the control group. NSCs transplantation was carried out in 
the right striatum of the stem cell macaque. SCs plus NSCs 
transplantation was carried out in the right striatum of the 
co-transplant macaque. Four caudate nucleus of right 
striatum target and four dorsal caudate putamen targets were 
chose as the transplant area, with 10 毺L suspension in each 
target.  
2.7. Selection of the transplant target
  According to the projection direct of dopaminergic 
neurofibril and the distribution area of the target cells, the 
targets were 4 right caudate nucleus targets and 4 dorsal 
caudate putamen targets (Table 2). 
2.8. Behavior evaluation 
  Gomez-Mancilla dyscinesia score scale was adopted[9]: A, 
Posture: normal, 0; flection to the injured side,1; flection to 
the injured opposite side; 2. B, Action: active, 1; passive, 2; 
without limb-like or fumble-like action, 0; with limb-like 
or fumble-like action, 1. C, walking: normal, 0; abnormal, 
1. D, getting food: normal, 0; abnormal, 1. E, communicate 
with other macaques: normal, 0; eluding, 1. F, cry, normal, 
0; obviously decreased, 1. G, limb trem of injured opposite 
side: inexistence, 0; existence, 1. Successful model 
evaluation score should be over 6 scores. For transplantation 
experiment, the score recovered to 0-4 score or the score 
decreased over 2 scores was considered as effectiveness. 
Behavior score of macaque was performed 1, 2, 3, 4, 5 and 6 
months after 6-OHDA injury operation and 2 weeks, 1, 2, 3, 
4, 5 and 6 months after transplantation.  
2.9. Validation of PD model and cell transplantation target 
with MRI
  Head cross section and coronal plane plain scan was 
performed with GE Signa 3.0T magnetic resonance imaging 
machine. The base line of cross section plain scanning was 
the audio orbital line, and the baseline of coronal plane 
was vertical to the audio orbital line. T1W and T2W imaging 
was performed by using SE sequence. MRI examination was 
performed 1 week after injure operation and 1 week after 
cell transplantation. 
Table 1 
Site of each injection target (mm).
Order of injection A ( before 0 point) R (right of 0 point) H (above of 0 point)
1 7.0 3.0 -0.5
2 9.0 2.5   0.7
3 6.5 2.7 -1.2
4 8.0 2.3   0.0
5 6.0 4.0 -0.9
6 7.5 3.3 -1.3
7 5.0 3.9   0.0
Table 2  
Coordinate value of transplant targets (mm).
Order of injection A ( before 0 point) R (right of 0 point) H (above of 0 point)
Right caput nuclei caudati 1 21.5 3.5 90.0
2 20.0 4.5 11.0
3 20.0 3.0 11.8
4 18.5 3.5 11.8
Right dorsal caudate putamen 1 20.0 8.5 11.0
2 19.5 8.0   8.5
3 19.0 8.5 10.0
4 18.5 8.5   8.0
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2.10. PET examination
  Positron emission computerized tomography (PET) was 
performed 6 months after 6-OHDA injury operation and 2 as 
well as 6 months after cell transplantation. The developer 
18F-N-(3-Fluoro-propyl)- 2毬-carbomethoxy-3毬-(4’-
Iodophenyl)demethyl tropane (18F-FP-毬-CIT) of dopamine 
transporter (DAT) was used for DAT examination. BIOGRAPH 
SENSATION 16 PET/ CT was purchased from Siemens, 
Germany.
2.11. Histology examination
2.11.1. Animal intravascular perfusion and sampling 
  Macaque brain was detected in histology 6 months after 
6-OHDA injure operation. Basal anesthesia was performed 
with 8 mg/kg ketamine followed by depth of anesthesia with 
50 mg/kg pentobarbital sodium. The heart was exposed after 
thoracotomy. The pericardium was cut, and the inferior 
vena cava was clasped. The infusion needle was inserted 
into left ventricle, and the right atrial appendage was cut 
open. The right atrial appendage was rapidly infused with 
1 000 mL warm sodium chloride, followed by 1 000 mL 4% 
paraformaldehyde fixation solution for 20 min fast followed 
by slow. After craniotomy, the brain was fixed for 5 days 
at 4 ℃. The coronal plane was determined according to 
the anatomical atlas. The brain tissue was cut in a coronal 
incision between A3 mm-A10 mm, and the striatum and 
substantia nigra were separated. The tissue was separated 
into two left and right pieces, and each was separated into 
trisection in coronal plane. These six tissues were numbered 
and placed into 10%, 20% and 30% sucrose solution in order 
for gradient dehydration. The tissues were removed after 
sinking, and embedded with embedding material. 30 毺m
brain slices were prepared with frozen section mechanism
 
2.11.2. TH immunohistochemical staining of brain tissue
  The steps of tyroxine hydroxylase (TH) immunohistochemical 
staining were shown as follows: 1) 30毺m paraffin section 
was conventionally deparaffined with xylene following 
gradient ethanol dehydration; 2) The sections were placed 
into Sodium Citrate buffer (pH6.0, 2.1 g/L), and treated 
with microwave for 5 min at 95 ℃, 5 min twice, and then 
cooled down at room temperature for 20 min; 3) The sections 
were rinsed with PBS for three times; 4) The sections were 
incubated with 5% calf serum+0.2% Triton伊100 for 24 h
at 4 ℃, and then incubated with the primary antibody 
(TH antibody 1:1 000) at 4 ℃ overnight; 5) The sections 
were rinsed with PBS for 10 min for three times; 6) Second 
antibody: The sections were incubated with biotinylation 
goat anti-rabbit IgG at room temperature for three hours; 
7) The sections were rinsed with PBS for 10 min for three 
times; 8) The sections were incubated with ABC reagent for 
1 h; 9) The sections were rinsed with PBS for 10 min for three 
times; 10) The colouration was performed with 0.04% DAB 
(containing 0.01% H2O2) for 5-20 min; 11) The sections were 
rinsed with lotic water; 12) The sections were sealed after 
common alcoholic dehydration and clearing with Xylene. 
All above steps were performed at room temperature except 
indicated. 
3. Results
3.1. Evaluation of macaque PD model
3.1.1. Behavior evaluation  
  Behavior observations indicated that three macaques 
immediately showed reduced contralateral limbs 
activity, hypermyotonia and gait abnormalities after right 
substantia nigra pars compacta injury. When they were 
fed, the macaques got the food with the right forelimb. The 
macaques showed sluggish facial expressions and decreased 
blinking. The left flexor showed hypermyotonia, presenting 
a special flexuosity stance and prostrate action. These three 
macaques reached 6-8 scores before transplantation, and 
reached unilateral PD standard. 
3.2.2. Injection target detected by MRI
  Three model macaques were examined with MRI. T2W 
sequence showed the clearest picture of the injured site. 
The target was accurately located in the substantia nigra of 
deutocerebrum. 
3.1.3. Results of PET examination
  PET examination for three model macaques showed that 
18F-FP-毬-CIT was significantly concentrated in the normal 
(left) striatum, while its radioactive uptake was significantly 
decreased in the injured (right) striatum. 
3.2. Culture and identification of human embryo NSCs
  The primary cells showed suspension growth. After 1 day, 
cells aggregated into a lump, forming different sizes of 
regular nerve spheres. Most of the cells had good refraction 
and powerful activity. Small amount of intercellular 
substance and cells still mixed in the cell suspension, 
with poor refraction. Cells still showed suspension growth 
after passage. The nerve spheres had good refraction and 
powerful activity. The intercellular substance, dead cells 
and cell debris were gradually decreased (Figure 1). Cells 
showed indirect immunofluorescence for Nestin (Figure 2). 
                  Figure 1                                                        Figure 2 
Figure 1. Suspension growth of NSCs (伊100). 
Figure 2. Indirection immunofluorescence result of NSCs(伊100). 
Ying Xia et al./Asian Pacific Journal of Tropical Medicine (2012)7-14 11
3.3. In vitro growth and identification of macaque autogeneic 
SCs
  Under inverted phase contrast microscope, cells grew 
surrounding the explant 48 h after explant culture. A large 
number of SCs grew followed by the initial fibroblasts. 
Schwann cell was spindle, with bipolar prominence 
and obvious oval nucleus. With the migration of cells to 
periphery, the density of SCs was gradually increased, 
connecting into pieces (Figure 3a). In the eugenic area, the 
SCs arranged in neat swirling shoulder by shoulder (Figure 
3b). SCs showed S-100 positive staining (Figure 4).
Figure 3a                                  Figure 3b                                Figure 4 
Figure 3. In vitro growth of SCs (伊100).
a: Growth after 1 week.
b: Growth after 4 weeks. 
Figure 4. S-100 positive staining of SCs(伊100). 
3.4. Behavior evaluation of transplanted macaques 
  The transplantation effect was observed from the second 
week after transplantation. The macaques in each group 
still showed decreased and slow actions. One month after 
transplant operation, the parameters of dyscinesia of the 
co-transplanted macaque recovered in different degree, 
while the stem cell transplanted macaque and the control 
macaque were not significantly changed. From the second 
month, the recovery degrees of the stem cell transplanted 
macaque and the control macaque were over 2 scores, 
indicating an effective transplantation. Up to 4 months after 
transplantation, the recovery has been near to normal. The 
left limb tremor of cell transplanted macaque disappeared, 
and the left forelimb could get the food independently 
and recovered the fine movement of getting raisins. The 
contralateral hypermyotonia was significantly improved, and 
the posture recovered to normal. The autonomic activities 























Figure 5. Behavior changes of macaques. 
3.5. MRI examination after transplantation
  MRI examination was performed in three model macaques. 
T2W sequence showed the clearest picture. The target was 
accurately located in the striatum area, which was seen in 
Figure 6a&b.
a b
Figure 6. MRI result after transplantation.
a: Cross section of T2W sequence.
b: Coronal section of T2W sequence. 
 
3.6. PET examination result after transplantation
  PET result showed that 18F-FP-毬-CIT was significantly 
radioactively concentrated in the normal (left) striatum, 
while its radioactive uptake was also significantly 
concentrated in the injured (right) striatum in the co-
transplanted macaque 2 months after transplantation. The 
radioactive uptake was a small quantity concentrated in 
the injured (right) striatum in the stem cell-transplanted 
macaque (Figure 7a-c). 6 months after transplantation, 18F-
FP-毬-CIT was significantly radioactively concentrated in 
the injured (right) striatum in the co-transplanted macaque 
and stem cell-transplanted macaque (Figure 8a-c).
a b c
Figure 7. PET result 2 months after transplantation.
a: PET result of co-transplantated macaque.
b: PET result of stem cell transplanted macaque.
c: PET result of control macaque. 
a b c
 
Figure 8. PET result 6 months after transplantation.
a: PET result of co-transplantated macaque.
b: PET result of stem cell transplanted macaque.
c: PET result of control macaque. 
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3.7. Immunohistochemistry of TH in transplanted brain 
tissue
  The immunohistochemical staining of transplanted area 
tissue showed that there was no TH positive cell in the 
striatum of the control macaque (Figure 9a). TH positive cells 
could be seen in the striatum of the stem cell-transplanted 
macaque (Figure 9b). In the co-transplanted macaque, the 
number of TH positive cells was significantly increased, and 
the cell prominence was also significantly increased (Figure 
9c). 
a b c





  So far, all methods for the treatment of PD are to make 
a balance between dopamine and acetylcholine under 
a pathological state, thus alleviating the symptoms, but 
not repairing nerve functions. However, the pathological 
changes of PD are relatively clear, and the sites of the 
pathological changes are relatively concentrated. Therefore, 
cell transplantation is relatively easy, and the clinical and 
pathological observations are also easier to implement.
  With the extension of time, commonly used levodopa 
(L-dopa) therapy will gradually show the decreased 
therapeutic efficacy and some complications[10-12]. 
Pallidotomy and electric stimulation of subthalamic nucleus 
have good therapeutic effects for improving movement 
disorders (especially caused by L-dopa), but less effects for 
tremor, and the long-term effect is poor, with the recurrence 
of many symptoms within a few years[13,14]. In recent years, 
deep brain stimulation (DBS) has gradually become more 
common. However, from the view of PD pathogenesis, DBS 
is still a symptomatic treatment, which can not prevent 
the progression of the disease, and no long-term effect 
was reported[15,16]. Cell transplantation is the best method 
for PD treatment from the view of theory. According to the 
anatomical characteristics of substantia nigra-striatum and 
the mode of action of dopamine neurons in the nerve ending 
of striatum area, transplantation of cells with dopamine-
secreting function can improve the deteriorated substantia 
nigra dopaminergic neuronal function of PD patients and 
restore the content of dopamine in the striatum, through a 
functional “biological micro-pump”, thus achieving a long-
term effect. 
  Animal experiments proved that stem cell transplantation 
was an effective therapeutic method for PD, but the 
therapeutic efficacy was unstable clinically, the main reason 
of which was the low cell survival rate. The transplanted 
cells can not obtain adequate nutrition because of the 
striatum lesion caused by the long-term course of PD. 
Simultaneously, various nutrition factors maintaining cell 
growth, differentiation and migration are lacking. Therefore, 
the prostecdtive efficacy of was poor in clinical trials[17-20]. 
According to the different mechanisms of transplanted cells, 
both stem cells and SCs could be transplanted together. Stem 
cells can cure PD through secreting dopamine, while SCs can 
improve the survival microenvironment of the transplanted 
stem cells and enhance the survival rate of the transplanted 
cells and the differentiation rate of the transplanted cells 
into dopaminergic neurons. 
  The establishment of PD animal model is the precondition 
of various experiments. So far, the mouse PD model and rat 
PD model have been established. These rodent models are 
able to replicate the clinical symptoms of PD under certain 
extent. Rat models are widely accepted by researchers due 
to its economy, easier establishment and direct behavior 
observation. However, it is not an ideal animal model for 
human PD due to its different pathophysiology from human 
PD. 
  The primate macaque PD model is an ideal animal model, 
but it is difficult to be applied widely due to its high price. 
So far, only a little research groups involved in this field. 
Only three unilateral 6-OHDA partial injure macaque 
PD model were adopted in our study due to the financial 
restriction. Human embryonic midbrain NSCs as well as the 
autologous SCs of macaque were adopted to further validate 
the efficacy and the clinical application possibility of the 
co-transplantation combined with MRI and PET. 
  Our experiment showed that the automatic action 
of 6-OHDA unilateral injured macaque PD model was 
significantly decreased, and hypermyotonia and resting 
tremor were shown in the contralateral limb. The macaque 
showed bradykinesia, gait irregularity, mask-like face 
and increased grovel action. The dyskinesia score was 
over 4 scores after 4 months. MRI examination proved that 
the accurate target is located in the substantia nigra. PET 
examination showed that the uptake of the injured striatum 
DAT developer 18F-FP-毬-CIT was significantly decreased. 
The model was stable and reliable, which was consistent 
with the requirement of experiment. Moreover, transplanted 
MRI revealed that the transplanted area of right striatum was 
accurate, which was also consistent with the requirement of 
experiment. 
  The effect of transplantation was observed two weeks 
after transplantation. The transplanted animals in each 
group still showed reduced movement of left limbs and 
the movement was slow. During the first month after 
transplantation, every dyskinesia parameters of the co-
transplantation macaque were recovered at different extents, 
while the SCs-transplanted macaque and the control 
macaque had no significant changes. After 2 months, the 
recovery extent of the SCs-transplanted macaque and 
the control macaque was over 2 points, suggesting that 
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the transplantation was effective. Up to 4 months after 
transplantation, the recovery has been near to normal. The 
left limb tremor of cell transplanted macaque disappeared, 
and the left forelimb could get the food independently 
and recovered the fine movement of getting raisins. The 
contralateral hypermyotonia was significantly improved, and 
the posture recovered to normal. The autonomic activities 
were significantly increased, while it was not significantly 
changed in the control macaque. All above suggested that 
cell transplantation was effective in both macaques, but the 
praxiology improvement was earlier in the co-transplanted 
macaque. 
  During the pathological and biochemical changes of PD, 
the changes of dopaminergic neuron number on presynaptic 
membrane of striatum up-regulates or down-regulates the 
corresponding receptors on postsynaptic membrane. The 
dopamine transporter (DAT) is also changed, and this change 
is more specific and more sensitive. Therefore, the change of 
functional activity and density DAT is an important indicator 
for reflecting the function of DA neurotransmitter system. 
As a membrane protein on the presynaptic membrane of 
dopaminergic neuron, the main function of DAT is to re-
uptake of DA from the synaptic gap and to regulate the 
information transfer of the interaction between DA and 
its receptor. About 3/4 DA is transferred to presynaptic 
membrane by DAT for re-use. Currently, the change of 
DA can not be observed by head CT and MRI. The changes 
of the function and the density of DAT on DA neurons 
presynaptic membrane are consistent with the change of 
DA neurons. Its functional imaging will benefit to reflect 
the pathological change of substantia nigra DA neurons in 
PD and evaluate the effects of cell transplantation[21-23]. In 
our study, the developer of DAT was F-18 or C-11 labeled 
cocaine derivative CIT. These developers have high affinity 
to DAT, and have low non-specificity uptake and a relative 
slow brain clearance rate. More than 95% of CIT can bind 
DAT in the basal ganglia after the intravenous injection. 
Therefore, it is an ideal imaging tracer for DAT. It can 
reflect the change information of presynaptic dopaminergic 
neuron directly and sensitively, and imaging earlier than the 
postsynaptic receptor. Therefore, it can reflect the change 
of presynaptic dopaminergic system timely, and has a good 
correlation with PD severity.
  PET result showed that 18F-FP-毬-CIT was significantly 
radioactively concentrated in the normal (left) striatum, while 
its radioactive uptake was also significantly concentrated in 
the injured (right) striatum in the co-transplanted macaque 
2 months after transplantation. The radioactive uptake 
was a small quantity concentrated in the injured (right) 
striatum in the stem cell-transplanted macaque. 6 months 
after transplantation, the developer of 18F-FP-毬-CIT was 
significantly radioactively concentrated in the injured 
(right) striatum in the co-transplanted macaque and stem 
cell-transplanted macaque, while it was not significantly 
changed in the control macaque. The above suggested that 
the function of the transplanted human embryonic stem cell 
presynaptic dopaminergic neuron had been established in 
the co-transplanted macaque 2 months after transplantation, 
while the function of the transplanted human embryonic 
stem cell presynaptic dopaminergic neuron had not been 
established in the stem cell-transplanted macaque at 
that time, and it recovered 6 months after transplantation. 
Although the function of the transplanted human embryonic 
stem cell presynaptic dopaminergic neuron had not been 
established in the stem cell-transplanted macaque 2 months 
after cell transplantation, the praxiology examination 
showed the effective transplantation, which may be related 
to the secreted DA by transplanted cells. Although the 
synapsis function of the transplanted cells was still not 
established, they could secrete DA, thus enhancing the 
DA content in the striatum and maintaining the balance 
between Dopamine and acetylcholine, therefore the 
symptoms were relieved. In the co-transplanted macaque, 
the existence of SCs could promote the transformation of 
NSCs to the dopaminergic neuron, the proliferation of nerve 
fiber, and the establishment of presynaptic dopaminergic 
neuron. In addition, the transplanted SCs in striatum may 
secrete various neurotrophic factors which improve the 
microenvironment of dopaminergic neuron in transplanted 
area. Simultaneously, it also promoted the growth and 
function recovery of the impaired striatum nerve fiber and 
promoted the budding of remained DA fiber, thus inducing 
the budding of DA fibers[24-26].
  TH staining of three macaques brain tissue in the 
transplantation showed that there was no TH-positive cells 
in the striatum of the control macaque and TH-positive 
cells could be seen in SCs-transplantation macaque; while 
increased TH-positive cells could be seen in the co-
transplantation macaque, and the protrusions around cells 
were also significantly increased.
  In summary, co-transplantation has been proved to be 
effective and feasible in both praxiology, molecule (DAT) and 
histology (brain tissue TH staining). SCs can be derived from 
the peripheral nerve of the patients. It is easy to be obtained 
and its injury for patients is small. In addition, patients do 
not have to worry about the rejection. Therefore, SCs are 
easy to be accepted by patients and also easy to be applied 
clinically.
  In short, the mechanisms of embryonic brain cell 
transplantation for treatment of PD may be different in the 
postoperative early stage and the later stage. The early 
effect is probably due to the graft-secreted DA, while the 
maintenance of long-term efficacy is dependent on the re-
domination of the transplanted DA fiber to the striatum. In 
our study, although the symptoms of co-transplantation 
macaque improved more rapidly, both SCs transplantation 
macaque and co-transplantation macaque were proved 
to be effective after 6 months observation. The long-term 
therapeutic effect of above two methods still needs to be 
further studied. 
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